Nifedipine and losartan effects on endothelial function during acute pharmacological test in arterial hypertension patients with various risk factors

Aim. To study nifedipine and losartan effects on endothelial function (EF) during acute pharmacological test (APT) in arterial hypertension (AH) patients with several risk factors (RF). Material and methods. The study included 94 patients with Stage I AH. All participants were divided into three gro...

Full description

Bibliographic Details
Main Authors: M. O. Argunova, A. G. Avtandilov
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2008-02-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/1055
_version_ 1797882726189105152
author M. O. Argunova
A. G. Avtandilov
author_facet M. O. Argunova
A. G. Avtandilov
author_sort M. O. Argunova
collection DOAJ
description Aim. To study nifedipine and losartan effects on endothelial function (EF) during acute pharmacological test (APT) in arterial hypertension (AH) patients with several risk factors (RF). Material and methods. The study included 94 patients with Stage I AH. All participants were divided into three groups: Group I – 31 AH patients with obesity (mean body mass index (BMI) 34,7±3,37 kg/m2); Group II – 32 smokers with AH and mean BMI 23,5±2,19 kg/m2; Group III - 31 AH patients with two RF (smoking and obesity) and mean BMI 35,1±3,72 кг/м2. Mean age was 47,9±8,2 years, mean AH duration - 12,4±2,0 years in Group I, 11,0±1,8 years in Group II, and 11,8±1,7 years in Group III. Angiotensin II receptor antagonist losartan was used as a comparison agent. All participants underwent general clinical examination. Endothelium dependent vasodilatation, diameters of common carotid artery and brachial artery, BA (Duplex method), linear blood flow velocities (peak systolic, maximal end diastolic, time averaged maximal velocities), and peripheral resistance index were measured. The participants received nifedipine (20 mg/d) and losartan (100 mg/d) once.  Results. Comparative analysis of two medications’ effectiveness demonstrated improved endothelium dependent vasodilatation during APT with nifedipine and losartan. After nifedipine APT, BA diameter significantly increased in Groups I and III, after losartan APT – in Group III.  Conclusion. Nifedipine improved EF in AH patients with various RF
first_indexed 2024-04-10T03:40:11Z
format Article
id doaj.art-3be70519640b468d97d2b26021a5f882
institution Directory Open Access Journal
issn 1728-8800
2619-0125
language Russian
last_indexed 2024-04-10T03:40:11Z
publishDate 2008-02-01
publisher «SILICEA-POLIGRAF» LLC
record_format Article
series Кардиоваскулярная терапия и профилактика
spelling doaj.art-3be70519640b468d97d2b26021a5f8822023-03-13T07:23:14Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252008-02-01712428768Nifedipine and losartan effects on endothelial function during acute pharmacological test in arterial hypertension patients with various risk factorsM. O. Argunova0A. G. Avtandilov1ГОУ ДПО «Российская медицинская академия последипломного образования Росздрава», г. МоскваГОУ ДПО «Российская медицинская академия последипломного образования Росздрава», г. МоскваAim. To study nifedipine and losartan effects on endothelial function (EF) during acute pharmacological test (APT) in arterial hypertension (AH) patients with several risk factors (RF). Material and methods. The study included 94 patients with Stage I AH. All participants were divided into three groups: Group I – 31 AH patients with obesity (mean body mass index (BMI) 34,7±3,37 kg/m2); Group II – 32 smokers with AH and mean BMI 23,5±2,19 kg/m2; Group III - 31 AH patients with two RF (smoking and obesity) and mean BMI 35,1±3,72 кг/м2. Mean age was 47,9±8,2 years, mean AH duration - 12,4±2,0 years in Group I, 11,0±1,8 years in Group II, and 11,8±1,7 years in Group III. Angiotensin II receptor antagonist losartan was used as a comparison agent. All participants underwent general clinical examination. Endothelium dependent vasodilatation, diameters of common carotid artery and brachial artery, BA (Duplex method), linear blood flow velocities (peak systolic, maximal end diastolic, time averaged maximal velocities), and peripheral resistance index were measured. The participants received nifedipine (20 mg/d) and losartan (100 mg/d) once.  Results. Comparative analysis of two medications’ effectiveness demonstrated improved endothelium dependent vasodilatation during APT with nifedipine and losartan. After nifedipine APT, BA diameter significantly increased in Groups I and III, after losartan APT – in Group III.  Conclusion. Nifedipine improved EF in AH patients with various RFhttps://cardiovascular.elpub.ru/jour/article/view/1055артериальная гипертонияфакторы рисканифедипинэндотелиальная функцияострая фармакологическая проба
spellingShingle M. O. Argunova
A. G. Avtandilov
Nifedipine and losartan effects on endothelial function during acute pharmacological test in arterial hypertension patients with various risk factors
Кардиоваскулярная терапия и профилактика
артериальная гипертония
факторы риска
нифедипин
эндотелиальная функция
острая фармакологическая проба
title Nifedipine and losartan effects on endothelial function during acute pharmacological test in arterial hypertension patients with various risk factors
title_full Nifedipine and losartan effects on endothelial function during acute pharmacological test in arterial hypertension patients with various risk factors
title_fullStr Nifedipine and losartan effects on endothelial function during acute pharmacological test in arterial hypertension patients with various risk factors
title_full_unstemmed Nifedipine and losartan effects on endothelial function during acute pharmacological test in arterial hypertension patients with various risk factors
title_short Nifedipine and losartan effects on endothelial function during acute pharmacological test in arterial hypertension patients with various risk factors
title_sort nifedipine and losartan effects on endothelial function during acute pharmacological test in arterial hypertension patients with various risk factors
topic артериальная гипертония
факторы риска
нифедипин
эндотелиальная функция
острая фармакологическая проба
url https://cardiovascular.elpub.ru/jour/article/view/1055
work_keys_str_mv AT moargunova nifedipineandlosartaneffectsonendothelialfunctionduringacutepharmacologicaltestinarterialhypertensionpatientswithvariousriskfactors
AT agavtandilov nifedipineandlosartaneffectsonendothelialfunctionduringacutepharmacologicaltestinarterialhypertensionpatientswithvariousriskfactors